Egalet Corp (NASDAQ:EGLT)

Data as of 10:42am ET
 +0.09 / +1.01%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Egalet Corp. is a specialty pharmaceutical company using its patented technology to produce novel therapeutics on its own and with partners. The company is developing a pipeline of tamper-resistant opioids that are nearing pivotal testing based on the proprietary technology. Its products include Egalet-001, Egalet-002 and AD Opioid. The company was founded in August 2013 and is headquartered in Malvern, PA.

Contact Information

Egalet Corp.
460 E. Swedesford Road
Wayne Pennsylvania 19087
P:(484) 875-3095
Investor Relations:



Individual stakeholders44.60%
Other institutional4.90%
Mutual fund holders18.82%

Top Executives

Robert Samuel RadiePresident, Chief Executive Officer & Director
Stanley J. MusialChief Financial Officer
Jeffrey M. DaynoChief Medical Officer
Karsten LindhardtVice President-Research & Development
Mark StrobeckChief Business Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.